Innocoll AG (NASDAQ:INNL) released its quarterly earnings results on Tuesday. The specialty pharmaceutical company reported ($0.51) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.48) by $0.03. Innocoll AG had a negative return on equity of 1,226.28% and a negative net margin of 1,139.95%.

Innocoll AG (NASDAQ:INNL) opened at 2.73 on Wednesday. Innocoll AG has a one year low of $2.20 and a one year high of $12.94. The company’s market capitalization is $66.48 million. The company has a 50-day moving average price of $4.70 and a 200-day moving average price of $6.10.

Earnings History for Innocoll AG (NASDAQ:INNL)

A number of equities analysts have recently issued reports on INNL shares. Zacks Investment Research downgraded Innocoll AG from a “buy” rating to a “hold” rating in a research note on Tuesday, October 18th. FBR & Co dropped their price target on Innocoll AG from $18.00 to $13.00 and set an “outperform” rating on the stock in a research note on Friday, November 4th. Finally, JMP Securities restated a “buy” rating on shares of Innocoll AG in a research note on Sunday, November 6th.

COPYRIGHT VIOLATION WARNING: This piece of content was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The original version of this piece of content can be viewed at

Innocoll AG Company Profile

Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.

5 Day Chart for NASDAQ:INNL

Receive News & Stock Ratings for Innocoll AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll AG and related stocks with our FREE daily email newsletter.